Showing 731-740 of 2280 results for "".
Clinical Use of Alzheimer Disease Biomarkers: Legal, Ethical, and Social Considerations
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-use-of-alzheimer-disease-biomarkers-legal-ethical-and-social-considerations/32141/Legal, ethical, and social considerations are emerging along with the clinical implementation of Alzheimer disease biomarkers.Diagnosis and Treatment of Neuro-Ophthalmologic Symptoms in People with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-treatment-of-neuro-ophthalmologic-symptoms-in-people-with-parkinson-disease/37656/Recognizing and addressing neuro-ophthalmologic signs and symptoms are essential for delivering comprehensive, patient-centered care and improving long-term outcomes in individuals with PD.Case Report: Hemiparkinsonism in a Patient With Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/movement-disorders/case-report-hemiparkinsonism-in-a-patient-with-multiple-sclerosis/31527/In this case, there was a causal relationship between comorbid diseases.Treating Stress to Improve Neurologic Outcomes
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/treating-stress-to-improve-neurologic-outcomes/30158/Research on the interaction between hormones and seizures supports the importance of helping patients manage stress.Migraine Acute Therapies
https://practicalneurology.com/diseases-diagnoses/headache-pain/migraine-acute-therapies/31513/Acute treatment of migraine improves daily function and reduces associated disability and risk of transformation to chronic migraine.Migraine Preventive Therapies in Development
https://practicalneurology.com/diseases-diagnoses/headache-pain/migraine-preventive-therapies-in-development/31512/The field of headache medicine is full of promise with more migraine-specific preventive therapies in development.- Movement Disorders Focushttps://practicalneurology.com/diseases-diagnoses/movement-disorders/pn0307-movedisorders-pdf/31203/Accurate assessment of movement disorders is crucial for clinicians to quantify their impact on patients’ quality of life and monitor disease progression. Practical Neurology’s recent article delves into various validated rating scales tailored for specific neurological conditions, enhancing objecti
Drugs in Development for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/drugs-in-development-for-multiple-sclerosis/31632/Stem cells, tyrosine kinase inhibitors, remyelinating agents, metabolically active molecules, and more are being tested as potential new disease-modifying treatments.Diagnostic & Treatment Delay in Temporal Lobe Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/diagnostic-treatment-delay-in-temporal-lobe-epilepsy/31835/The average 20-year delay of referral to epilepsy centers can be improved.Neuromuscular Notes: Autoantibodies in Immune Myopathies
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-notes-autoantibodies-inimmune-myopathies/31543/Antibody testing results provide clinically useful information.